These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9835528)

  • 1. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA.
    Falla TJ; Chopra I
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3282-4. PubMed ID: 9835528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones.
    Goldman JD; White DG; Levy SB
    Antimicrob Agents Chemother; 1996 May; 40(5):1266-9. PubMed ID: 8723480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HipA-triggered growth arrest and β-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis.
    Bokinsky G; Baidoo EE; Akella S; Burd H; Weaver D; Alonso-Gutierrez J; García-Martín H; Lee TS; Keasling JD
    J Bacteriol; 2013 Jul; 195(14):3173-82. PubMed ID: 23667235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli.
    Correia FF; D'Onofrio A; Rejtar T; Li L; Karger BL; Makarova K; Koonin EV; Lewis K
    J Bacteriol; 2006 Dec; 188(24):8360-7. PubMed ID: 17041039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Oethinger M; Kern WV; Goldman JD; Levy SB
    J Antimicrob Chemother; 1998 Jan; 41(1):111-4. PubMed ID: 9511045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
    Gómez-Martínez J; Marco F; Mensa J; Espasa M; Martínez JA; Jiménez de Anta MT
    Rev Esp Quimioter; 1999 Mar; 12(1):54-7. PubMed ID: 10209063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pMEX01, a 70kb plasmid isolated from Escherichia coli that confers resistance to multiple β-lactam antibiotics.
    Hernandez-Flores JL; Pérez JC; Gutiérrez CS; Hernández AC; Alonso GS; Hernández SP; Gómez SR; Fernández F; Loske AM; Guillén JC
    Braz J Microbiol; 2018; 49(3):569-574. PubMed ID: 29449172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HipBA-promoter structures reveal the basis of heritable multidrug tolerance.
    Schumacher MA; Balani P; Min J; Chinnam NB; Hansen S; Vulić M; Lewis K; Brennan RG
    Nature; 2015 Aug; 524(7563):59-64. PubMed ID: 26222023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug resistant escherichia coli with extended-spectrum beta-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs.
    Warren A; Townsend K; King T; Moss S; O'Boyle D; Yates R; Trott DJ
    Aust Vet J; 2001 Sep; 79(9):621-3. PubMed ID: 11702934
    [No Abstract]   [Full Text] [Related]  

  • 12. Cadaverine biosynthesis contributes to decreased Escherichia coli susceptibility to antibiotics.
    Akhova A; Nesterova L; Shumkov M; Tkachenko A
    Res Microbiol; 2021; 172(7-8):103881. PubMed ID: 34543694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First characterization of fluoroquinolone resistance mechanisms in CTX-M-producing Escherichia coli from Mongolia.
    Kao CY; Udval U; Wu HM; Bolormaa E; Yan JJ; Khosbayar T; Wu JJ
    Infect Genet Evol; 2016 Mar; 38():79-81. PubMed ID: 26692472
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.
    Emrich NC; Heisig A; Stubbings W; Labischinski H; Heisig P
    J Antimicrob Chemother; 2010 Dec; 65(12):2530-3. PubMed ID: 20940181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.
    Webber MA; Piddock LJ
    Antimicrob Agents Chemother; 2001 May; 45(5):1550-2. PubMed ID: 11302826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine.
    Moore JE; Alcorn M; Rendall JC; Downey DG
    Br J Biomed Sci; 2015; 72(3):146-9. PubMed ID: 26510272
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
    Wang H; Dzink-Fox JL; Chen M; Levy SB
    Antimicrob Agents Chemother; 2001 May; 45(5):1515-21. PubMed ID: 11302820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The product of the qacC gene of Staphylococcus epidermidis CH mediates resistance to beta-lactam antibiotics in gram-positive and gram-negative bacteria.
    Fuentes DE; Navarro CA; Tantaleán JC; Araya MA; Saavedra CP; Pérez JM; Calderón IL; Youderian PA; Mora GC; Vásquez CC
    Res Microbiol; 2005 May; 156(4):472-7. PubMed ID: 15862444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.